Plenivida Health

Website
HealthTech,Consumer

Company Bio

Visit website ↗Explore our full portfolio & program companies
Founders

LvlUp insightsGenerated from LvlUp’s portfolio data and the company’s own updates
Similar companies

More in the LvlUp portfolio

See all →

Building something ambitious?

LvlUp Ventures backs founders from first check to late stage.

Apply for funding
Fabricio Alves
Pre-Seed
United States
HealthTech, Consumer
2026
Plenivida sells an all-in medical membership to women aged 30 to 60 in the US who pay cash for peptide, GLP-1 and, from 2027, hormone care, in English and Spanish. Each plan bundles baseline labs, a physician consultation, compounded medication from 503A pharmacies, shipping and follow-up. The first buyers are women already buying peptides outside any clinic and women on a GLP-1 who want more than a vial. At day 90 the patient is re-tested, and the renewal is a lighter maintenance plan adjusted to her results. The first prepaid plan pays back its own acquisition cost. Plenivida owns the intake, the protocol design, the patient relationship and the compliance layer; physicians and pharmacies are contracted partners, so there is no inventory and no clinical payroll. Plenivida Health is LegitScript-certified since October 2026.

Plenivida is a LegitScript-certified peptide therapy platform. We help midlife women get measurable gains in energy, body composition and recovery with physician-led peptide protocols built for her.